News
6 Nov 2019
Method Development, Verification & Validation of NDMA & other impurities
LCMS/MS [API & Finished Dosage Form]
Accuprec Research Labs Pvt. Ltdhas successfully doneMethod Development, Verification & Validation of NDMA impurities in Ranitidine through LCMS/MS [API & Finished Dosage Form] as per USFDA method.
Key Features of Developed Method:
LoD = 0.2 ppb
LoQ = 0.6 ppb
% Recovery = 99.47 %
We have also done method validation for other impurities: NDEA, NEIPA, NDIPA, NDBA & NMBA
Mentioned Companies
ACCUPREC RESEARCH LABS PVT. LTD
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance